Lv51
924 积分 2021-12-02 加入
Reflections on Alnylam
5天前
已完结
515LBA (PB-515) LBA Posters: CID-078, a first-in-class oral macrocycle cyclin A/B-RxL inhibitor, demonstrates anti-tumor activity in E2F-driven cancers
11天前
已完结
Risk characterization of N-nitrosodimethylamine in pharmaceuticals
12天前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
20天前
已完结
Drugging RNA
26天前
已完结
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors – a review of patent literature from 2019–June 2023
1个月前
已完结
SMARCA2 protein: structure, function and perspectives of drug design
1个月前
已完结
Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once‐weekly dosing for the treatment of patients with diabetes
1个月前
已完结
Insulin Allergy: The Allergist’s Updated Approach to Evaluation and Management
1个月前
已完结
JAK inhibitor selectivity: new opportunities, better drugs?
1个月前
已完结
皖公网安备34019202002308
